ALK-Abelló
Organisation
Trials
Phase 2Completed201066 people30 Aug 2010clinicaltrials.gov
Phase 2Completed2009473 people9 Mar 2009clinicaltrials.gov
Phase 3Completed2006154 people4 Apr 2006clinicaltrials.gov
Organisation
Phase 2Completed201066 people30 Aug 2010clinicaltrials.gov
Phase 2Completed2009473 people9 Mar 2009clinicaltrials.gov
Phase 3Completed2006154 people4 Apr 2006clinicaltrials.gov